- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07635329
Home-based Vision Rehabilitation Guided by Brain Imaging (BRIGHT)
Behavioral Rehabilitation Through Image-Guided Home-based Training
The BRIGHT (Behavioral Rehabilitation Through Image-Guided Home-based Training) study aims to evaluate the effectiveness of image-guided, home-based perceptual training at improving visual performance in individuals with visual field loss.
Using a prospective, crossover design, BRIGHT combines visual behavioral testing, neuroimaging, and a home-based intervention. It aims to 1) identify neural pathways that support training-induced visual plasticity; and 2) compare the efficacy of different types of visual training delivered in a home-based setting.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tina Liu, PhD
- Phone Number: 2027849920
- Email: tina.liu@georgetown.edu
Study Locations
-
-
District of Columbia
-
Washington D.C., District of Columbia, United States, 20057
- Recruiting
- Georgetown University Medical Center
-
Principal Investigator:
- Tina Liu, PhD
-
Contact:
- Tina Liu, PhD
- Phone Number: 202-784-9949
- Email: vpplab@georgetown.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- At least 18 years of age.
- Capable of providing informed consent and complying with study procedures.
- Unilateral or bilateral focal brain damage causing visual field loss.
- At least three months post-stroke or traumatic brain injury, or a stable brain tumor within the past year.
- Eligible for MRI based on standard safety screening.
Exclusion Criteria:
- Severe neurological or psychiatric conditions unrelated to the focal lesion that may interfere with study participation or data interpretation.
- Current or recent (within the past 6 months) drug or alcohol abuse or addiction as defined by DSM-5.
- Ocular disease or disorder.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Perceptual learning-based training using high-level visual stimuli
A 3 week at-home online perceptual learning-based training using high-level visual stimuli.
|
Behavioral intervention consisting of repeated computerized visual discrimination tasks targeting higher-order visual processing
|
|
Active Comparator: Perceptual learning-based training using low-level visual stimuli
A 3 week at-home online perceptual learning-based training using low-level visual stimuli.
|
behavioral intervention consisting of repeated computerized visual discrimination tasks targeting low-level visual processing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in high-level perceptual discrimination performance
Time Frame: Week 2-4 or Week 7-9 of the study (depending on the order)
|
Change in performance on an online computerized high-level perceptual discrimination task.
Participants complete a computerized high-level perceptual discrimination task during a 3-week training period (5 days per week).
Task difficulty is adaptively adjusted using a 3-up/1-down staircase procedure to estimate perceptual discrimination thresholds corresponding to approximately 75% accuracy.
|
Week 2-4 or Week 7-9 of the study (depending on the order)
|
|
Change in low-level perceptual discrimination performance
Time Frame: Week 2-4 or Week 7-9 of the study (depending on the order)
|
Change in performance on an online computerized low-level perceptual discrimination task.
Participants complete a computerized high-level perceptual discrimination task during a 3-week training period (5 days per week).
Task difficulty is adaptively adjusted using a 3-up/1-down staircase procedure to estimate perceptual discrimination thresholds corresponding to approximately 75% accuracy.
|
Week 2-4 or Week 7-9 of the study (depending on the order)
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases
- Cardiovascular Diseases
- Wounds and Injuries
- Neoplasms by Site
- Neoplasms
- Eye Diseases
- Vision Disorders
- Sensation Disorders
- Nervous System Neoplasms
- Craniocerebral Trauma
- Trauma, Nervous System
- Central Nervous System Neoplasms
- Blindness
- Brain Injuries
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Brain Injuries, Traumatic
- Stroke
- Brain Neoplasms
- Hemianopsia
- Blindness, Cortical
Other Study ID Numbers
- STUDY00010314
- 26CDA1590827 (Other Grant/Funding Number: American Heart Association)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on High-level perceptual learning-based training
-
University of Texas at AustinCompletedHealthy Subjects | Neuropsychiatric DisordersUnited States
-
Georgetown UniversityRecruitingStroke | Brain Tumor | Traumatic Brain Injury | Visual Field Defect, Peripheral | Hemianopia | Quadrantanopia | Cortical Blindness | Visual Field DefectUnited States
-
Nova Southeastern UniversityRecruitingAmblyopiaUnited States
-
University of California, BerkeleyNational Eye Institute (NEI)Completed
-
University of California, BerkeleyNational Eye Institute (NEI)Completed
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityEnrolling by invitation
-
Siriraj HospitalUnknown
-
University of British ColumbiaCompletedAging | Wheelchair TrainingCanada
-
Samsung Medical CenterRecruitingNSCLC | CT | Neoadjuvant ChemoimmunotherapySouth Korea
-
Peking University People's HospitalTibet Autonomous Region People's HospitalCompletedIntubation Time | Simulation Training | Flexible BronchoscopyChina